Home > Animal Health & Nutrition > Animal Drug Compounding Market > Table of Contents

Animal Drug Compounding Market – By Animal Type (Companion, Livestock), Drug Type (Anti-infective, Anti-inflammatory, Hormones & substitutes, CNS], Dosage Form (Oral, Topical, Injectable), Distribution Channel – Global Forecast 2024 – 2032

  • Report ID: GMI10492
  • Published Date: Jul 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising prevalence of chronic disease in animals

3.2.1.2    Growing regulatory support

3.2.1.3    Advancements in veterinary medicine

3.2.1.4    Growing pet ownership and spending

3.2.2    Industry pitfalls & challenges

3.2.2.1    Limited awareness and acceptance

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Future market trends

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Companion animals

5.3    Livestock animals

Chapter 6   Market Estimates and Forecast, By Drug Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Anti-infective agents

6.3    Anti-inflammatory agents

6.4    Hormones & substitutes

6.5    CNS agents

6.6    Other drug types

Chapter 7   Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Oral

7.2.1    Tablets

7.2.2    Capsules

7.2.3    Liquids

7.2.4    Other oral dosage forms

7.3    Topical

7.3.1    Ointments

7.3.2    Creams

7.3.3    Gels

7.3.4    Sprays

7.4    Injectable

7.5    Other dosage forms

Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Veterinary hospitals pharmacies

8.3    Compounding pharmacies

8.4    Other distribution channels

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    The Netherlands

9.3.7    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6    Middle East and Africa

9.6.1    Saudi Arabia

9.6.2    South Africa

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    AVRIO Pharmacy

10.2    New Era Pharmacy

10.3    NexGen Pharmaceuticals

10.4    Pace Pharmacy

10.5    SaveWay Compounding Pharmacy

10.6    ScriptWorks

10.7    SCIRx Pharmacy

10.8    Summit Veterinary Pharmacy Ltd.

10.9    Triangle Compounding Pharmacy

10.10    The Pet Apothecary

10.11    Veterinary Pharmaceutical Solutions

10.12    Veterinary Specialty Pharmacy

10.13    WEDGEWOOD PHARMACY
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 373
  • Countries covered: 22
  • Pages: 170
 Download Free Sample